{"title": "New imaging tools that trace key breast cancer enzymes may help guide therapies", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/medical_devices.xml", "value": "New imaging tools that trace key breast cancer enzymes may help guide therapies"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/12/181206120059.htm"}], "link": "https://www.sciencedaily.com/releases/2018/12/181206120059.htm", "summary": "A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/medical_devices.xml", "value": "A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers."}, "published": "Thu, 06 Dec 2018 12:00:59 EST", "published_parsed": [2018, 12, 6, 17, 0, 59, 3, 340, 0], "id": "https://www.sciencedaily.com/releases/2018/12/181206120059.htm", "guidislink": false}